您的位置：首页 > 产品中心 > 322-79-2， Triflusal
Triflusal
产品价格查看更多规格...
| 产品编号 | 包装单位 | 单价(元) | 国内现货 | 国外库存 | 询价单 |
| 3255250 | 5 MG | 1340 |
产品别名
322-79-2
Triflusal
α,α,α-trifluoro-2,4-cresotic acid acetate
2-(Acetyloxy)-4-(trifluoromethyl)benzoic acid
Drisgen
acetyl-4-trifluoromethylsalicylic acid
基本信息
| Empirical Formula【经验(实验)分子式】 | C10H7F3O4 |
| Molecular weight | 248.16 |
| EC number【EC 号】 | 206-297-5 |
| NACRES | NA.25 |
| Biochem/physiol Actions【生化/生理作用】 | Triflusal is an anti-inflammatory antithrombotic platelet aggregation inhibitor with a 3-fold mechanism of action. It is an irreversible inhibitor of COX-1 inhibiting thromboxane A2, preventing aggregation; it preserves vascular prostacyclin, thus promoting anti-aggregant effect. Triflusal blocks phosphodiesterase leading to an increase in cAMP levels promoting anti-aggregant effect due to inhibition of calcium mobilization. |
| Features and Benefits【特点和优势】 | This compound was developed by Uriach. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here. |
产品性质
| Quality Level【质量水平】 | 100 |
| Assay【测定】 | ≥98% (HPLC) |
| form【形式】 | powder |
| color【颜色】 | white to off-white |
| solubility【溶解性】 | DMSO: >30 mg/mL |
| originator【创始人】 | Uriach |
| storage temp.【储存温度】 | 2-8℃ |
| InChI | 1S/C10H7F3O4/c1-5(14)17-8-4-6(10(11,12)13)2-3-7(8)9(15)16/h2-4H,1H3,(H,15,16) |
| InChI key | RMWVZGDJPAKBDE-UHFFFAOYSA-N |
| packaging【包装】 | 5, 25 mg in glass bottle |
安全信息
| Pictograms【象形图】 | GHS07 |
| Signal word【警示用语：】 | Warning |
| Hazard Statements | H302 - H315 - H317 - H319 - H335 |
| Precautionary Statements | P280 - P301 + P312 + P330 - P302 + P352 - P305 + P351 + P338 |
| Hazard Classifications【危险分类】 | Acute Tox. 4 Oral - Eye Irrit. 2 - Skin Irrit. 2 - Skin Sens. 1 - STOT SE 3 |
| Target Organs【靶器官】 | Respiratory system |
| Storage Class Code【储存分类代码】 | 11 - Combustible Solids |
| WGK | WGK 3 |
